An Interview with A Mentor- Dr. Robert Langer, Sc.D. (MIT Institute Professor) on aspects of the Future of Diabetes Medicine Research

0:00-10:49

An Interview with A Mentor- Dr. Robert Langer, Sc.D. (MIT Institute Professor) on aspects of the Future of Diabetes Medicine Research ====== Diabetes therapy is entering a new phase. For decades, the central challenge was how to deliver insulin more safely, more intelligently, and more responsively. The research work by Dr. Langer has produced a generation of technologies aimed at making therapy more autonomous: glucose-responsive insulin systems, microneedle patches, implantable rescue devices, lipid nanoparticles, and mRNA-based approaches to protein replacement. At the same time, a separate revolution emerged from pharmacology. GLP-1 receptor agonists, dual GIP/GLP-1 agonists, and now triple GIP/GLP-1/glucagon agonists have changed expectations for the treatment of type 2 diabetes and obesity. ===== Music by ⁠ANDRII KORNIEV⁠ from ⁠Pixabay⁠ ==== Views of this interview reflect those of my guest and I. They don't constitute medical or professional advice. We disclaim any loss in any way.

Publisher

"Lecture-casts"- A Lecture Series on General Chemistry

Link

podcasters.spotify.com/pod/show/dj-ferguson9/episodes/An-Interview-with-A-Mentor--Dr--Robert-Langer--Sc-D--MIT-Institute-Professor-on-aspects-of-the-Future-of-Diabetes-Medicine-Research-e3mpb4i

Published

July 31, 2026

Duration

11 min

Format

Podcast

Category

Issues · Science

Source

RSS feed

Host

D.J. Ferguson

"A

"Lecture-casts"- A Lecture Series on General Chemistry

@lecturecastsalectureserieson

#robertlanger #mitinstituteprofessor #diabetesmedicineresearch #chemistry

The Nile